Magenta Therapeutics, Inc.

Edigene Biotechnology Inc.

Kevin A Goncalves

Arthur Glenn Romero

Anthony Boitano

Michael P Cooke

Dwight Morrow

Patrick C Falahee

Michael Cooke

The invention provides compositions and methods useful for mobilizing populations of hematopoietic stem and progenitor cells within a donor, as well as for determining whether samples of mobilized cells are suitable for release for ex vivo expansion and/or therapeutic use. In accordance with the compositions and methods described herein, mobilized hematopoietic stem and progenitor cells can be withdrawn from a donor and administered to a patient for the treatment of various stem cell disorders, including hematopoietic diseases, metabolic disorders, cancers, and autoimmune diseases, among others. In certain embodiments, the compositions and methods described herein lead to the mobilization of a population of CD34cells that have immunosuppressive effects and that can reduce the incidence of graft vs. host disease.

Dosing regimens for the mobilization of hematopoietic stem and progenitor cells

Described herein are compositions and methods useful for mobilizing populations of hematopoietic stem and progenitor cells within a subject, as well as for determining whether samples of mobilized cells are suitable for release for ex vivo expansion and/or therapeutic use. In accordance with the composition and methods described herein, mobilized hematopoietic stem and progenitor cells can be withdrawn from a donor and administered to a patient for the treatment of various disorders, including hematopoietic diseases, metabolic disorders, cancers, and autoimmune diseases, among others.

Dosing regimens for the mobilization of hematopoietic stem cells

Growing community of inventors

Boston, MA, United States of America

Kevin A Goncalves